Top Markets
#1 Helium Helium +94.28%
#2 MowCat MowCat +80.93%
#3 Seeker Seeker +59.15%
#4 UnifAI Network UnifAI Network +34.35%
#5 Tensor Tensor +31.21%
#6 TENDIES TENDIES +26.57%
#7 AI XOVIA AI XOVIA +24.77%
#8 Pons Pons +24.26%
#9 Zylo Ecosystem Zylo Ecosystem +21.75%
#10 Bounce Bounce +18.99%
Coin of the day
Helium Helium
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
BridgeBio Oncology Therapeutics Inc. BridgeBio Oncology Therapeutics Inc.

BridgeBio Oncology Therapeutics Inc.

BBOT
Classifica tra le azioni #11443
BridgeBio Oncology Therapeutics functions as a clinical-stage biopharmaceutical... BridgeBio Oncology Therapeutics functions as a clinical-stage biopharmaceutical firm dedicated to pioneering advanced small molecule treatments. These therapies are aimed at combating malignancies driven by RAS and PI3Kα, both frequently encountered oncogenes in human cancers. Initially established as an offshoot of BridgeBio Pharma, the company concentrates on precision oncology. Its developmental pipeline features several promising programs, including BBO-8520, BBO-10203, and BBO-11818, all specifically designed to modulate the KRAS and PI3K pathways. The company recently became publicly traded through a business combination with Helix Acquisition Corp. II. This strategic move successfully raised approximately $450 million, which will be utilized to further its clinical development initiatives. The leadership team comprises Dr. Eli Wallace as Chief Executive Officer and Dr. Pedro Beltran as Chief Scientific Officer.
Prezzo delle azioni
$8.74
Ultima sincronizzazione: 2026-08-28
Capitalizzazione di mercato
$699.74M
Variazione (1 giorno)
-4.85%
Variazione (1 anno)
-2.29%
Paese
US
Scambia BridgeBio Oncology Therapeutics Inc. (BBOT)

Categoria

Healthcare
Il prezzo BBOT con la capitalizzazione del mercato della B
BridgeBio Oncology Therapeutics Inc. BridgeBio Oncology Therapeutics Inc.
BBOT
$8.74
Capitalizzazione di mercato di BridgeBio Oncology Therapeutics Inc.(BBOT)
Capitalizzazione di mercato: $699.74M
A partire dal August 2026, BridgeBio Oncology Therapeutics Inc. ha una capitalizzazione di mercato pari a $699.74M. Questo rende BridgeBio Oncology Therapeutics Inc. la 11443rd azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di BridgeBio Oncology Therapeutics Inc. dal 2024 al 2026
BBOT in paragone con la classifica dei più popolari stocks
Il prezzo per BBOT Attivo B Capitalizzazione del mercato a B Risultati
BridgeBio Oncology Therapeutics Inc. BridgeBio Oncology Therapeutics Inc.
$65,710.37 $699.74M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.264T +752,165.28%
BridgeBio Oncology Therapeutics Inc. BridgeBio Oncology Therapeutics Inc.
$58,687.38 $699.74M
Apple Inc. Apple Inc.
AAPL
$4.701T +671,764.65%
BridgeBio Oncology Therapeutics Inc. BridgeBio Oncology Therapeutics Inc.
$52,144.91 $699.74M
Alphabet Inc. Alphabet Inc.
GOOG
$4.177T +596,865.19%
BridgeBio Oncology Therapeutics Inc. BridgeBio Oncology Therapeutics Inc.
$47,653.71 $699.74M
Microsoft Corporation Microsoft Corporation
MSFT
$3.817T +545,449.10%
BridgeBio Oncology Therapeutics Inc. BridgeBio Oncology Therapeutics Inc.
$35,781.31 $699.74M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.866T +409,531.44%